BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 11198485)

  • 1. Clinical improvement in patients with orthostatic intolerance after treatment with bisoprolol and fludrocortisone.
    Freitas J; Santos R; Azevedo E; Costa O; Carvalho M; de Freitas AF
    Clin Auton Res; 2000 Oct; 10(5):293-9. PubMed ID: 11198485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible sympathetic vasomotor dysfunction in POTS patients.
    Freitas J; Santos R; Azevedo E; Costa O; Carvalho M; de Freitas AF
    Rev Port Cardiol; 2000 Nov; 19(11):1163-70. PubMed ID: 11201632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Postural orthostatic tachycardia syndrome (POTS): etiology, diagnosis and therapy].
    Grubb BP; Klingenheben T
    Med Klin (Munich); 2000 Aug; 95(8):442-6. PubMed ID: 10985065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and physiological effects of an acute alpha-1 adrenergic agonist and a beta-1 adrenergic antagonist in chronic orthostatic intolerance.
    Stewart JM; Munoz J; Weldon A
    Circulation; 2002 Dec; 106(23):2946-54. PubMed ID: 12460877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Orthostatic intolerance syndromes].
    Gónzalez-Hermosillo JA
    Arch Cardiol Mex; 2001; 71 Suppl 1():S58-62. PubMed ID: 11565347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case reports and review of Postural Orthostatic Tachycardia syndrome (POTS).
    Carothers B; Schmidt L; Puri V
    J Ky Med Assoc; 2003 Dec; 101(12):549-52. PubMed ID: 14689686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autonomic nervous system dysfunction in adolescents with postural orthostatic tachycardia syndrome and chronic fatigue syndrome is characterized by attenuated vagal baroreflex and potentiated sympathetic vasomotion.
    Stewart JM
    Pediatr Res; 2000 Aug; 48(2):218-26. PubMed ID: 10926298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autonomic dysfunction presenting as postural orthostatic tachycardia syndrome in patients with multiple sclerosis.
    Kanjwal K; Karabin B; Kanjwal Y; Grubb BP
    Int J Med Sci; 2010 Mar; 7(2):62-7. PubMed ID: 20309394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperadrenergic postural tachycardia syndrome in mast cell activation disorders.
    Shibao C; Arzubiaga C; Roberts LJ; Raj S; Black B; Harris P; Biaggioni I
    Hypertension; 2005 Mar; 45(3):385-90. PubMed ID: 15710782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postural tachycardia syndrome in syringomyelia: response to fludrocortisone and beta-blockers.
    Nogués M; Delorme R; Saadia D; Heidel K; Benarroch E
    Clin Auton Res; 2001 Aug; 11(4):265-7. PubMed ID: 11710800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular responses to orthostatic stress in patients with postural tachycardia syndrome (POTS), in patients with low orthostatic tolerance, and in asymptomatic controls.
    Bush VE; Wight VL; Brown CM; Hainsworth R
    Clin Auton Res; 2000 Oct; 10(5):279-84. PubMed ID: 11198483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysautonomia: A Forgotten Condition - Part 1.
    Rocha EA; Mehta N; Távora-Mehta MZP; Roncari CF; Cidrão AAL; Elias Neto J
    Arq Bras Cardiol; 2021 Apr; 116(4):814-835. PubMed ID: 33886735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pooling in chronic orthostatic intolerance: arterial vasoconstrictive but not venous compliance defects.
    Stewart JM
    Circulation; 2002 May; 105(19):2274-81. PubMed ID: 12010910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Certain cardiovascular indices predict syncope in the postural tachycardia syndrome.
    Sandroni P; Opfer-Gehrking TL; Benarroch EE; Shen WK; Low PA
    Clin Auton Res; 1996 Aug; 6(4):225-31. PubMed ID: 8902319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic profile and heart rate variability in hyperadrenergic versus non-hyperadrenergic postural orthostatic tachycardia syndrome.
    Crnošija L; Krbot Skorić M; Adamec I; Lovrić M; Junaković A; Mišmaš A; Miletić V; Šprljan Alfirev R; Pavelić A; Habek M
    Clin Neurophysiol; 2016 Feb; 127(2):1639-1644. PubMed ID: 26386646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The preponderance of initial orthostatic hypotension in postural tachycardia syndrome.
    Stewart JM; Kota A; O'Donnell-Smith MB; Visintainer P; Terilli C; Medow MS
    J Appl Physiol (1985); 2020 Sep; 129(3):459-466. PubMed ID: 32702262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular perturbations in the chronic orthostatic intolerance of the postural orthostatic tachycardia syndrome.
    Stewart JM; Weldon A
    J Appl Physiol (1985); 2000 Oct; 89(4):1505-12. PubMed ID: 11007589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Postural orthostatic tachycardia syndrome (POTS): report of 15 cases].
    Jiménez-Cohl P; Earle NM; González BR; Thieck EJ
    Rev Med Chil; 2012 Feb; 140(2):145-52. PubMed ID: 22739942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The postural orthostatic tachycardia syndrome: a neurocardiogenic variant identified during head-up tilt table testing.
    Grubb BP; Kosinski DJ; Boehm K; Kip K
    Pacing Clin Electrophysiol; 1997 Sep; 20(9 Pt 1):2205-12. PubMed ID: 9309745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fludrocortisone and sleeping in the head-up position limit the postural decrease in cardiac output in autonomic failure.
    van Lieshout JJ; ten Harkel AD; Wieling W
    Clin Auton Res; 2000 Feb; 10(1):35-42. PubMed ID: 10750642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.